Cargando…

MDR1 Inhibition Reverses Doxorubicin-Resistance in Six Doxorubicin-Resistant Canine Prostate and Bladder Cancer Cell Lines

Acquired chemoresistance during chemotherapy, often accompanied by cross- and multi-resistance, limits therapeutic outcomes and leads to recurrence. In order to create in vitro model systems to understand acquired doxorubicin-resistance, we generated doxorubicin-resistant sublines of canine prostate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Packeiser, Eva-Maria, Engels, Leoni, Nolte, Ingo, Goericke-Pesch, Sandra, Murua Escobar, Hugo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179448/ https://www.ncbi.nlm.nih.gov/pubmed/37175843 http://dx.doi.org/10.3390/ijms24098136

Ejemplares similares

Metformin and sodium dichloroacetate effects on proliferation, apoptosis, and metabolic activity tested alone and in combination in a canine prostate and a bladder cancer cell line
por: Klose, Katharina, et al.
Publicado: (2021)

Characterization of six canine prostate adenocarcinoma and three transitional cell carcinoma cell lines derived from primary tumor tissues as well as metastasis
por: Packeiser, Eva-Maria, et al.
Publicado: (2020)

Insights into Canine Infertility: Apoptosis in Chronic Asymptomatic Orchitis
por: Morawietz, Judith, et al.
Publicado: (2023)

Evaluation of combination protocols of the chemotherapeutic agent FX-9 with azacitidine, dichloroacetic acid, doxorubicin or carboplatin on prostate carcinoma cell lines
por: Weiner, Franziska, et al.
Publicado: (2021)

Isoquinolinamine FX-9 Exhibits Anti-Mitotic Activity in Human and Canine Prostate Carcinoma Cell Lines
por: Schille, Jan Torben, et al.
Publicado: (2019)

RNA-seq of nine canine prostate cancer cell lines reveals diverse therapeutic target signatures
por: Packeiser, Eva-Maria, et al.
Publicado: (2022)

Comparison of non-coding RNAs in human and canine cancer
por: Wagner, Siegfried, et al.
Publicado: (2013)

Reversal of doxorubicin-resistance by Salvia miltiorrhiza ligustrazine in the SHG44/doxorubicin glioma drug-resistant cell line
por: Wang, Feng, et al.
Publicado: (2017)

The In Vitro Contractile Response of Canine Pregnant Myometrium to Oxytocin and Denaverine Hydrochloride
por: Jungmann, Carolin, et al.
Publicado: (2023)

An RNA-Seq-Based Framework for Characterizing Canine Prostate Cancer and Prioritizing Clinically Relevant Biomarker Candidate Genes
por: Thiemeyer, Heike, et al.
Publicado: (2021)

Role of the aclacinomycin A--doxorubicin association in reversal of doxorubicin resistance in K562 tumour cells.
por: Millot, J. M., et al.
Publicado: (1989)

Salinomycin enhances doxorubicin-induced cytotoxicity in multidrug resistant MCF-7/MDR human breast cancer cells via decreased efflux of doxorubicin
por: KIM, KWANG-YOUN, et al.
Publicado: (2015)

Curcumin reverses doxorubicin resistance via inhibition the efflux function of ABCB4 in doxorubicin-resistant breast cancer cells
por: Wen, Chunjie, et al.
Publicado: (2019)

Involvement of Oxytocin and Progesterone Receptor Expression in the Etiology of Canine Uterine Inertia
por: Jungmann, Carolin, et al.
Publicado: (2022)

Detection of spermatogonial stem cells in testicular tissue of dogs with chronic asymptomatic orchitis
por: Reifarth, Larena, et al.
Publicado: (2023)

A-770041 reverses paclitaxel and doxorubicin resistance in osteosarcoma cells
por: Duan, Zhenfeng, et al.
Publicado: (2014)

Resveratrol reverses multidrug resistance in human breast cancer doxorubicin-resistant cells
por: HUANG, FANG, et al.
Publicado: (2014)

Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance
por: Zhao, Yuan, et al.
Publicado: (2016)

miR-205 Reverses MDR-1 Mediated Doxorubicin Resistance via PTEN in Human Liver Cancer HepG2 Cells
por: Li, Mei, et al.
Publicado: (2022)

Sinomenine Sensitizes Multidrug-Resistant Colon Cancer Cells (Caco-2) to Doxorubicin by Downregulation of MDR-1 Expression
por: Liu, Zhen, et al.
Publicado: (2014)

Crizotinib and Doxorubicin Cooperatively Reduces Drug Resistance by Mitigating MDR1 to Increase Hepatocellular Carcinoma Cells Death
por: Shao, Ming, et al.
Publicado: (2021)

Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells
por: Wang, Xu, et al.
Publicado: (2019)

Olmutinib Reverses Doxorubicin Resistance in ETS1-Overexpressing Leukemia Cells
por: Zhong, Jiansheng, et al.
Publicado: (2020)

Breviscapine reverses doxorubicin resistance in breast cancer and its related mechanisms
por: Fu, Weijiang, et al.
Publicado: (2023)

Hypoxia-ameliorated photothermal manganese dioxide nanoplatform for reversing doxorubicin resistance
por: Chen, Zhenzhen, et al.
Publicado: (2023)

Quercetin reverses the doxorubicin resistance of prostate cancer cells by downregulating the expression of c-met
por: Shu, Yan, et al.
Publicado: (2018)

Celecoxib Prevents Doxorubicin-Induced Multidrug Resistance in Canine and Mouse Lymphoma Cell Lines
por: Karai, Edina, et al.
Publicado: (2020)

Generation and Characterisation of a Canine EGFP-HMGA2 Prostate Cancer In Vitro Model
por: Willenbrock, Saskia, et al.
Publicado: (2014)

Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukaemia cells.
por: Ramu, A., et al.
Publicado: (1984)

Corrigendum: Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells
por: Wang, Xu, et al.
Publicado: (2020)

Interaction of WBP2 with ERα increases doxorubicin resistance of breast cancer cells by modulating MDR1 transcription
por: Chen, Shuai, et al.
Publicado: (2018)

Retraction: Sinomenine Sensitizes Multidrug-Resistant Colon Cancer Cells (Caco-2) to Doxorubicin by Downregulation of MDR-1 Expression
por: Liu, Zhen, et al.
Publicado: (2019)

Modulation of doxorubicin resistance in a doxorubicin-resistant human leukaemia cell by an immunoliposome targeting transferring receptor.
por: Suzuki, S., et al.
Publicado: (1997)

miR‐495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression
por: Zou, Zhenyou, et al.
Publicado: (2017)

Phase I Study of Intravenous PSC‐833 and Doxorubicin: Reversal of Multidrug Resistance
por: Minami, Hironobu, et al.
Publicado: (2001)

CD44 Contributes to the Regulation of MDR1 Protein and Doxorubicin Chemoresistance in Osteosarcoma
por: Gerardo-Ramírez, Monserrat, et al.
Publicado: (2022)

Dichloroacetate affects proliferation but not apoptosis in canine mammary cell lines
por: Harting, Tatjana P., et al.
Publicado: (2017)

Doxorubicin-conjugated dexamethasone induced MCF-7 apoptosis without entering the nucleus and able to overcome MDR-1-induced resistance
por: Chaikomon, Kamontip, et al.
Publicado: (2018)

Fulvestrant reverses doxorubicin resistance in multidrug-resistant breast cell lines independent of estrogen receptor expression
por: Huang, Yuan, et al.
Publicado: (2017)

Nanolipoparticles-mediated MDR1 siRNA delivery reduces doxorubicin resistance in breast cancer cells and silences MDR1 expression in xenograft model of human breast cancer
por: Nourbakhsh, Mahnaz, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8gjc73uvd4pa0mgq38l0dtsipg